1. Home
  2. CLSD vs NTIC Comparison

CLSD vs NTIC Comparison

Compare CLSD & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • NTIC
  • Stock Information
  • Founded
  • CLSD 2011
  • NTIC 1970
  • Country
  • CLSD United States
  • NTIC United States
  • Employees
  • CLSD N/A
  • NTIC 95
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • NTIC Industrial Specialties
  • Sector
  • CLSD Health Care
  • NTIC Industrials
  • Exchange
  • CLSD Nasdaq
  • NTIC Nasdaq
  • Market Cap
  • CLSD 68.6M
  • NTIC 68.1M
  • IPO Year
  • CLSD 2016
  • NTIC N/A
  • Fundamental
  • Price
  • CLSD $0.92
  • NTIC $7.38
  • Analyst Decision
  • CLSD Strong Buy
  • NTIC Buy
  • Analyst Count
  • CLSD 5
  • NTIC 1
  • Target Price
  • CLSD $5.20
  • NTIC $20.00
  • AVG Volume (30 Days)
  • CLSD 103.8K
  • NTIC 33.8K
  • Earning Date
  • CLSD 05-14-2025
  • NTIC 04-10-2025
  • Dividend Yield
  • CLSD N/A
  • NTIC 2.99%
  • EPS Growth
  • CLSD N/A
  • NTIC N/A
  • EPS
  • CLSD N/A
  • NTIC 0.38
  • Revenue
  • CLSD $1,664,000.00
  • NTIC $84,445,763.00
  • Revenue This Year
  • CLSD N/A
  • NTIC $2.05
  • Revenue Next Year
  • CLSD $675.15
  • NTIC $4.70
  • P/E Ratio
  • CLSD N/A
  • NTIC $19.26
  • Revenue Growth
  • CLSD N/A
  • NTIC 2.11
  • 52 Week Low
  • CLSD $0.70
  • NTIC $6.75
  • 52 Week High
  • CLSD $1.65
  • NTIC $19.63
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 62.45
  • NTIC 35.86
  • Support Level
  • CLSD $0.81
  • NTIC $7.28
  • Resistance Level
  • CLSD $0.90
  • NTIC $7.60
  • Average True Range (ATR)
  • CLSD 0.05
  • NTIC 0.20
  • MACD
  • CLSD 0.01
  • NTIC 0.14
  • Stochastic Oscillator
  • CLSD 99.85
  • NTIC 52.88

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.

Share on Social Networks: